Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Data Sheet 1_Artificial intelligence–enhanced mapping of the international classification of functioning, disability and health via a mobile app: a randomized controlled trial.zip... by Zhandos Kurban (21985553)

“…A total of 185 adult inpatients (≥18 years) were randomized to either a control group using paper questionnaires or an experimental group using the MedQuest app. …”

Image 1_Caffeine on the mind: EEG and cardiovascular signatures of cortical arousal revealed by wearable sensors and machine learning—a pilot study on a male group.jpeg by Shabbir Chowdhury (22246345)

“…Although systolic and diastolic BP showed a non-significant upward trend, HR decreased significantly after caffeine intake (77 ± 5.3 bpm to 72 ± 2.5 bpm, p = 0.027). …”

Characterization of Developmentally Dynamic Promoters (DDPs). by Jiang Tan (260415)

Effect of NLRP3 inhibition on expression of phenotypic transition markers in CER treated VSMCs during Vascular Calcification. by Razia Rashid Rahil (22772495)

“…Bar graphs depicted prior treatment with MCC950 significantly increased mRNA expression of (C) SM22α and decreased (D) RUNX2 in CER-treated P_i<i>‐</i>induced VSMCs. …”

Caffeine induces proteome-wide changes in a Rob-dependent manner. by Christoph Binsfeld (21763112)

“…The double-sided Fisher’s exact test p-value for enrichment of OMPs among significantly decreased proteins is shown. (D) Comparison of proteome changes between wild type and Δ<i>rob</i> upon caffeine treatment. …”

Cortical and subcortical regions feature distinct early and late responses during audition. by Sarah H. McGill (22505225)

“…The mean no-stimulus trial spectrograms were subtracted from the mean maximum-intensity trial spectrograms, and a cluster-based permutation testing was employed to identify significant differences between the conditions (p < 0.05, 5000 iterations). …”

Passive listening and go/No-go tasks feature comparable electrophysiological responses. by Sarah H. McGill (22505225)

“…The mean no-stimulus trial spectrograms were subtracted from the mean maximum-intensity trial spectrograms, and a cluster-based permutation testing was employed to identify significant differences between the conditions (p < 0.05, 5000 iterations). …”

Hemodynamic mechanisms underlying orthostatic hypotension in stroke survivors: a cross-sectional study by Kazuaki Oyake (7481357)

“…</p> <p>This study aimed to determine whether orthostatic hypotension is more strongly associated with a marked cardiac output decrease or an impaired total peripheral resistance increase among individuals with stroke.…”

Effect of Gasdermin-D inhibition on expression of phenotypic transition markers in CER treated VSMCs during Vascular Calcification. by Razia Rashid Rahil (22772495)

“…(E-F) Representative western blots and summarized bar graph showed DIS significantly increased protein expression of SM22α and decreased RUNX2 in CER treated P_i-induced VSMCs. …”

Effect of Gasdermin-D inhibition on CER-induced pyroptosis in P_i<i>‐</i>treated VSMCs. by Razia Rashid Rahil (22772495)

Effect of NLRP3 inhibition on CER-induced pyroptosis in P_i<i>‐</i>treated VSMCs. by Razia Rashid Rahil (22772495)

Supplementary Material for: Trends in the Incidence of Rare Eyelid Malignancies: A SEER-Based Study (2000–2021) by figshare admin karger (2628495)

“…For SGC; ARIMA (0,0,0) model demonstrated a decline in IR in 2011 (IR = 0.0192), increase until 2019, then decrease in 2021 (IR = 0.0246), with a predicted 10-year decrease to 0.026 (95% PI: 0.019–0.032). …”